Bruker Overview
- Year Founded
-
1960

- Status
-
Public
- Employees
-
11,396

- Stock Symbol
-
BRKR

- Investments
-
104
- Share Price
-
$42.36
- (As of Tuesday Closing)
Bruker General Information
Description
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Contact Information
Website
www.bruker.comCorporate Office
- 40 Manning Road
- Billerica, MA 01821
- United States
Corporate Office
- 40 Manning Road
- Billerica, MA 01821
- United States
Bruker Stock Performance
As of 08-Jul-2025, Bruker’s stock price is $42.36. Its current market cap is $6.42B with 152M shares.
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$42.36 | $41.27 | $34.10 - $72.94 | $6.42B | 152M | 2.45M | $0.52 |
Bruker Financials Summary
As of 31-Mar-2025, Bruker has a trailing 12-month revenue of $3.45B.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 8,428,074 | 11,192,489 | 11,061,856 | 10,597,404 |
Revenue | 3,446,100 | 3,366,400 | 2,964,500 | 2,530,700 |
EBITDA | 406,100 | 429,300 | 668,000 | 515,900 |
Net Income | 79,600 | 113,100 | 427,200 | 296,600 |
Total Assets | 5,933,100 | 5,806,700 | 4,249,900 | 3,611,800 |
Total Debt | 2,113,800 | 2,245,300 | 1,379,600 | 1,270,400 |
Bruker Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Bruker Comparisons
Industry
Financing
Details
Bruker Competitors (13)
One of Bruker’s 13 competitors is Revvity, a Corporation company based in Waltham, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Revvity | Corporation | Waltham, MA | ||||
Sysmex (Diagnostic Equipment) | Corporation | Kobe, Japan | ||||
Bio-Rad Laboratories | Corporation | Hercules, CA | ||||
GE HealthCare Technologies | Corporation | Chicago, IL | ||||
Sagence Technologies | Corporation | Calgary, Canada |
Bruker Patents
Bruker Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-202500898-D0 | Apparatus and method for generation of ions from sample material | Pending | 25-Jan-2024 | ||
DE-102024139408-A1 | Storage ion mobility separator with a moving electric field barrier | Pending | 29-Dec-2023 | ||
US-20250218756-A1 | Trapped ion mobility separator with a moving electric field barrier | Pending | 29-Dec-2023 | ||
GB-202417331-D0 | Trapped ion mobility seperator with a moving electric field barrier | Pending | 29-Dec-2023 | ||
DE-102024135778-A1 | Mass recalibration for mass spectrometry data | Pending | 22-Dec-2023 | H01J49/0036 |
Bruker Signals
Bruker Investments & Acquisitions (104)
Bruker’s most recent deal was a Merger/Acquisition with Biocrates. The deal was made on 02-Jun-2025.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Biocrates | 02-Jun-2025 | Merger/Acquisition | Biotechnology | ||
Recipe Chemicals + Instruments | 16-Apr-2025 | Merger/Acquisition | Diagnostic Equipment | ||
Ridom | 11-Apr-2025 | Merger/Acquisition | Other Healthcare Technology Systems | ||
Terrain Bio | 12-Feb-2025 | Seed Round | Biotechnology | ||
Akribion Therapeutics | 04-Feb-2025 | Seed Round | Biotechnology |
Bruker ESG
Risk Overview
Risk Rating
Updated May, 31, 2024
19.53 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,697
Rank
Percentile

Pharmaceuticals
Industry
of 847
Rank
Percentile

Laboratory Equipment and Services
Subindustry
of 59
Rank
Percentile

Bruker Exits (6)
Bruker’s most recent exit was on 16-Nov-2022 from Haystack Oncology. The exit was categorized as with 4 buyers.
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Haystack Oncology | 16-Nov-2022 | Completed |
|
||
Ionpath | 24-Sep-2020 | Completed |
|
||
Bruker (ICP-MS Business) | 19-May-2010 | Completed |
|
||
Spectral Solutions | 01-Jun-2007 | Completed |
|
||
VACUUMSCHMELZE | 01-Jun-2003 | Merger/Acquisition | Completed |
Bruker Affiliates
Subsidiaries (30)
Name | Industry | Location | Year Founded |
---|---|---|---|
Acuity Spatial Genomics | Santa Barbara, CA | 2021 | |
Interherence | Erlangen, Germany | 2019 | |
MIRO Analytical | Wallisellen, Switzerland | 2016 | |
Canopy Biosciences | Saint Louis, MO | 2016 | |
Zontal | Plantation, FL | 2016 |
Bruker FAQs
-
When was Bruker founded?
Bruker was founded in 1960.
-
Where is Bruker headquartered?
Bruker is headquartered in Billerica, MA.
-
What is the size of Bruker?
Bruker has 11,396 total employees.
-
What industry is Bruker in?
Bruker’s primary industry is Diagnostic Equipment.
-
Is Bruker a private or public company?
Bruker is a Public company.
-
What is Bruker’s stock symbol?
The ticker symbol for Bruker is BRKR.
-
What is the current stock price of Bruker?
As of 08-Jul-2025 the stock price of Bruker is $42.36.
-
What is the current market cap of Bruker?
The current market capitalization of Bruker is $6.42B.
-
What is Bruker’s current revenue?
The trailing twelve month revenue for Bruker is $3.45B.
-
Who are Bruker’s competitors?
Revvity, Sysmex (Diagnostic Equipment), Bio-Rad Laboratories, GE HealthCare Technologies, and Sagence Technologies are some of the 13 competitors of Bruker.
-
What is Bruker’s annual earnings per share (EPS)?
Bruker’s EPS for 12 months was $0.52.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »